All
Pair of Melanoma Studies Usher in a New Standard of Therapy for Patients with Advanced Disease
Melanoma studies with Yervoy and vemurafenib show benefit in advanced disease.
Aromasin Reduces Breast Cancer Risk in Healthy Older Women
Aromasin (exemestane) provides alternative option for postmenopausal women in breast cancer prevention.
Iniparib Disappoints in Breast Cancer, But Study Results Hint at Second-Line Therapy Benefit
Latest study results on PARP inhibitor iniparib disappointing, but may be helpful in second-line therapy.
Biomarker Reveals Who Is at Highest Risk for Neuropathy
Biomarker research might reveal neuropathy risk with certain cancer therapies.
Men May Be at Greater Risk Than Women for Developing HPV-Related Cancers
HPV-positive oral cancers are on the rise.
Avastin Continues to Show Impressive Results in Ovarian Cancer
Avastin appears to reduce relative risk of disease progression in recurring ovarian cancer.
Measuring Circulating Tumor Cells Could Predict Prostate Cancer Treatment’s Success
New cancer cell-trapping method could result in improved treatment.
The evolving PARP inhibitor story
Celebrating Life
Dr. Younes highlights important lymphoma studies from ASCO
For acute lymphoblastic leukemia patients, new hope from an old treatment
New treatment offers relief from bone marrow disorder
Early-phase melanoma study adds to "Melanoma" ASCO
A one-in-a-billion chance at success
Men may be at greater risk than women of developing HPV-related cancer
No longer at war?
Phase 1 trial shows promise in personalized therapy approach
Forty years later
CURE's "beat cancer" playlist
A preview of ASCO – The new way of doing clinical trials
No one deserves lung cancer
Erin Kramp's Legacy
What we're working on
Flash mob for a cure
Good dog!
Cynthia Nixon talks about cancer and "Sex and the City"
Oncology Nurses
Investigational drug for GIST is on the fast track
Q&A with Cynthia Nixon
CURE's Lena Huang sits down with actress Cynthia Nixon to discuss how cancer has affected her life.
Film offers powerful images of John Kaplan's lymphoma journey
